Cargando…

The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the (682)YENPTY(687) motif

Neurodegenerative diseases are characterized by the progressive decline of neuronal function in several brain areas, and are always associated with cognitive, psychiatric, or motor deficits due to the atrophy of certain neuronal populations. Most neurodegenerative diseases share common pathological...

Descripción completa

Detalles Bibliográficos
Autor principal:	Matrone, Carmela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2023
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860402/ https://www.ncbi.nlm.nih.gov/pubmed/36698966 http://dx.doi.org/10.1016/j.csbj.2023.01.008

Ejemplares similares

A new molecular explanation for age-related neurodegeneration: The Tyr682 residue of amyloid precursor protein
por: Matrone, Carmela
Publicado: (2013)

Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer’s Disease Patients
por: Iannuzzi, Filomena, et al.
Publicado: (2020)

Might Fibroblasts from Patients with Alzheimer’s Disease Reflect the Brain Pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr(682) Residue
por: Iannuzzi, Filomena, et al.
Publicado: (2021)

Y(682)G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP–SorLA Interaction
por: La Rosa, Luca Rosario, et al.
Publicado: (2015)

Tandem Mass Spectrometry as Strategy for the Selective Identification and Quantification of the Amyloid Precursor Protein Tyr682 Residue Phosphorylation Status in Human Blood Mononuclear Cells
por: Reveglia, Pierluigi, et al.
Publicado: (2021)

Correction: Iannuzzi et al. Might Fibroblasts from Patients with Alzheimer’s Disease Reflect the Brain Pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr682 Residue. Brain Sci. 2021, 11, 103
por: Iannuzzi, Filomena, et al.
Publicado: (2023)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

NAD(+) Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
por: Obrador, Elena, et al.
Publicado: (2021)

Serum programmed cell death proteins in amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2021)

Count of Fasciculation in Ultrasound Can Predict the Prognosis of Amyotrophic Lateral Sclerosis
por: Todo, Hiroyuki, et al.
Publicado: (2019)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
por: Cox, Laura M., et al.
Publicado: (2022)

Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation†
por: Zhou, Lujia, et al.
Publicado: (2011)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life
por: Grande, Giulia, et al.
Publicado: (2017)

Pre-Morbid Risk Factors for Amyotrophic Lateral Sclerosis: Prospective Cohort Study
por: Batty, G David, et al.
Publicado: (2021)

Acute retigabine‐induced effects on myelinated motor axons in amyotrophic lateral sclerosis
por: Sleutjes, Boudewijn T. H. M., et al.
Publicado: (2022)

Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis
por: Müller, Hans-Peter, et al.
Publicado: (2023)

Duration of observation required in detecting fasciculation potentials in amyotrophic lateral sclerosis using high-density surface EMG
por: Zhou, Ping, et al.
Publicado: (2012)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
por: Corcia, Philippe, et al.
Publicado: (2012)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
por: Schirò, Giuseppe, et al.
Publicado: (2022)

Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017)

Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
por: Ravnik-Glavač, Metka, et al.
Publicado: (2020)

Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis
por: Barbo, Maruša, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis
por: Chen, Lu, et al.
Publicado: (2020)

Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment
por: Wormser, Uri, et al.
Publicado: (2016)

Rare TBK1 variants in patients with frontotemporal dementia and amyotrophic lateral sclerosis in a Chinese cohort
por: Jiao, Bin, et al.
Publicado: (2018)

The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis
por: Tanaka, Hirotaka, et al.
Publicado: (2012)

Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
por: Krakora, Dan, et al.
Publicado: (2012)

The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
por: Lovejoy, David B., et al.
Publicado: (2014)

Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis
por: Dolinar, Ana, et al.
Publicado: (2019)

Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Novak, Valentina, et al.
Publicado: (2021)

Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis
por: Jiang, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_akb6d86gg93c811umifk8u30oh